Clinical Trial Update: A Study of 2 Doses of MAP0010 in Adult Asthmatics [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two doses of MAP0010 in adult asthmatics has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MAP0010

Snippet

Sponsor: Allergan | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-10-23